S.aureus protein STAAU R2, gene encoding it and uses thereof

Details for Australian Patent Application No. 2002220422 (hide)

Owner Targanta Therapeutics Inc.

Inventors Dubow, Michael; Bergeron, Dominique; Pelletier, Jerry; Gros, Philippe

Agent Spruson & Ferguson

Pub. Number AU-B-2002220422

PCT Pub. Number WO02/44718

Priority 09/727,892 01.12.00 US; 09/885,561 20.06.01 US

Filing date 30 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 28 June 2007

International Classifications

G01N 21/64 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Fluorescence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/005 (2006.01) Peptides having more than 20 amino acids - from viruses

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 21/27 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 21/78 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/483 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Physical analysis of biological material

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/542 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

28 August 2003 Amendment Made

  The nature of the amendment is: Amend the priority details from 09727892 30 Nov 2000 to 09727892 1 Dec 2000

24 March 2005 Change of Name(s) of Applicant(s), Section 104

  Phagetech, Inc. The name of the applicant has been changed to Targanta Therapeutics Inc.

28 June 2007 Application Accepted

  Published as AU-B-2002220422

25 October 2007 Standard Patent Sealed

25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002220423

2002220421